One pill and a team: the CATCH trial

In 40 primary care clinics in Colombia and Jamaica, a single combination pill plus a team that acted on home readings brought far more patients under control than usual care.

Share
One pill and a team: the CATCH trial

🎧 Listen: Weekly · Nov 16, from 09:27.

The question

A blood pressure target only helps the patients who reach it. In low- and middle-income countries, only about 14% of people with hypertension have it under control. CATCH asked whether a simpler regimen, delivered by a team, could close that gap in routine primary care.

What was done

A pragmatic trial that randomized 40 primary care clinics, 20 in Colombia and 20 in Jamaica, rather than individual patients. It enrolled 1,706 adults with uncontrolled hypertension; 98% were already taking blood pressure drugs, and the average starting systolic was about 145. People with advanced CKD were excluded.

The intervention clinics changed two things. First, the pills: patients were switched to a single combination pill, two or three blood pressure drugs in one tablet (usually valsartan with amlodipine, adding a thiazide when needed). Second, a package of care around it: a home blood pressure monitor for every patient, nurses who reviewed clinic and home readings and passed them to the doctors, community health workers who coached patients on taking their pills, and regular feedback to the clinic. The usual-care clinics had clinician training in measuring blood pressure and in the guideline, and could prescribe combination pills too.

What they found

Over 18 months, systolic pressure fell about 19 points with the intervention and about 9 with usual care. About 70% of intervention patients were under 130/80 at 18 months, against 29% with usual care. Six months after the program ended, 56% against 34% were still under 130/80, and three quarters of the intervention group were still on the combination pill, which insurers and the government kept covering. Serious adverse events were similar.

Our take

The trial measured blood pressure, not heart attacks or strokes. But lowering pressure from where these patients started is well established to prevent those events, so a ten-point drop very likely matters. The trial can't separate the pill from the team; the authors say the package is the point. Two pieces travel to any clinic: make the regimen simpler, and have someone who looks at the home readings and acts on them.


The source: Lopez-Lopez JP, Duncan J, Chen J, et al. Implementation of Single-Pill Combination Therapy Through Team-Based Care for Hypertension Control in Resource-Constrained Settings. JAMA. Published online November 8, 2026. doi:10.1001/jama.2026.24169 Read the original

🎧 Listen: Weekly · Nov 16, from 09:27.

Physician-led, AI-assisted. Dr. Wael Hussein chooses every item NephSpace covers and reviews and edits every story before it is published. The first draft was written in our own words with AI (Claude, by Anthropic) from the full text of the paper and checked against our reading notes; Dr. Hussein then reviewed and edited it. For education and information only, not medical advice. Please talk to your own physician or care team about your health. Clinicians: read the original before changing practice. See our disclaimer and disclosures. Spotted an error? Tell us.